A Single-shot Genetic Vaccination for Life-Long Protection Against Heart Attack | Qiurong Ding

TL;DR

A study on editing pcsk9 gene for heart protection using CRISPR technology.

Transcript

have you ever won a lottery I never have not even the smallest one so I'm always jealous of people who have a very lucky hand but do you know there are some people who are even not here they win the genetic lottery so some of those people are discovered in 2005 they were from Texas USA so they are very well protected from having heart attack even t... Read More

Key Insights

• 😘 Some individuals possess a genetic mutation that naturally protects them from heart disease by having ultra-low LDL cholesterol levels.
• 👻 CRISPR technology allows for precise genetic editing, offering the potential to replicate this protective effect by modifying the pcsk9 gene in liver cells.
• 🥰 Initial tests on mice suggest a significant reduction in blood cholesterol levels and a potential 90% decrease in heart disease risk.
• 🦺 Safety and efficacy must be ensured before advancing CRISPR technology for cardiovascular protection in humans.
• 🏆 Humanized mice models are being used to test CRISPR technology targeting human genes for further insights on safety and effectiveness.
• ❓ CRISPR technology has the potential to revolutionize genetic therapy by offering protective variants and correcting disease-causing mutations permanently.
• 🥰 Future applications of CRISPR technology may extend to preventing heart disease, managing genetic diseases, and potentially eradicating HIV.

Questions & Answers

Q: How do some individuals naturally have low LDL cholesterol levels?

Some individuals have a genetic mutation that prevents the production of the pcsk9 protein, resulting in ultra-low LDL cholesterol levels and protection against heart disease.

Q: How does CRISPR technology work in editing the pcsk9 gene?

CRISPR technology functions like genetic editing tools, allowing scientists to precisely edit the genome by deleting the pcsk9 gene in liver cells to replicate the protective effect seen in those with the mutation.

Q: What were the results of the initial testing on mice with edited pcsk9 genes?

The study showed a disruption in the pcsk9 gene in all liver cells, leading to a 40% reduction in blood cholesterol levels, potentially reducing heart disease risk by up to 90%.

Q: What are the next steps in advancing this research towards human application?

Further studies involve ensuring the safety and efficacy of CRISPR technology in humanized mice before moving on to human trials to potentially provide lifelong protection against heart disease.

Summary & Key Takeaways

• Certain individuals have a genetic mutation that protects them from heart disease by having very low LDL cholesterol levels due to the absence of the pcsk9 protein.

• Scientists are exploring CRISPR technology to edit the pcsk9 gene in liver cells to mimic this protective effect.

• Initial tests on mice show a significant reduction in blood cholesterol, potentially leading to a 90% decrease in heart risk.